Ｐａｇｅ 1178436 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ ＩＮＤＥＸ ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼severaL Brain Benef Kennethfus 17/5/10(水) 17:08 ─────────────────────────────────────── ■題名 ： severaL Brain Benef ■名前 ： Kennethfus <kennethfmorris811@gmail.com> ■日付 ： 17/5/10(水) 17:08 ■Ｗｅｂ ： http://viroquaemptybowls.blogspot.com/2017/04/1-truong-ai-hoc-my-ua-phap-luan-cong.html -------------------------------------------------------------------------
| News today announced the Salk team expanded after their previous development of a drug candidate, called J147, which takes a different tack by aimed towards Alzheimer's major risk factor-old age. Inside the new work, the team revealed that the drug prospect worked well in a mouse model of increasing age not typically used in Alzheimer's research. When these mice were treated with J147, they had better memory and cognition, much healthier blood vessels in the brain and other increased physiological features, News today announced "Initially, the impetus was going to test this drug in a novel animal model that was more similar to 99 pct of Alzheimer's cases, " claims Antonio Currais, the business lead author and a call of Professor David Schubert's Cellular Neurobiology Laboratory at Salk. "We would not predict we'd see this type of anti-aging effect, but J147 made old mice appear like they were young, structured on a number of physiological parameters. " News today announced alzheimer's disease is a developing brain disorder, recently placed as the 3 rd leading cause of death in the United States and affecting more than five million Americans. It is also the most typical cause of dementia in older people, in line with the National Institutes of Health. "While most drugs developed in the previous 20 years target the amyloid plaque deposits in the brain (which are a trademark of the disease), none have proven effective in the medical clinic, " claims Schubert, elderly author of the research. Increasing the Fight to Extra Common DementiasSeveral years in the past, Schubert and his acquaintances started to approach the treatment of the disease from a new position. Tin mi hm nay cho bit nhm Salk m mang chng trnh ln mnh vn dng ma ty trc y ca h, c gi l J147, s hu mt cch tip cn khc nhau bng cch nhm ch tiu ti nhn t nguy c chnh ca bnh Alzheimer. Trong nghin cu mi ny, lc lng nghin cu ch ra rng ng vin v thuc khin cho vic phi chng trong m phng lo ha chut khng thng c s dng trong nghin cu ca Alzheimer. lc nhng con chut ny c iu tr bng J147, chng mang tr tng v nhn thc r hn, cc mch mu khe mnh hn trong no v cc tnh nng sinh l ci tin khc chifoodbiz.blogspot.com Tin mi hm nay cho hay ng Antonio Currais, tc fake chnh v l thnh vin ca Phng th im Sinh l hc Cellular ca Gio s David Schubert ti Salk, cho bit: "Ban u, ng lc l th nghim ci thuc ny trong 1 m hnh ng vt mi l, nh vy nh 99% trng hp mc bnh Alzheimer. "Chng ti khng d on chng ta s thy hiu ng chng lo ha ny, nhng J147 lm chut gi trng ging nh chng cn tr, da trn 1 s tham s sinh l." Tin mi hm nay cho bit bnh Alzheimer l bnh ri lon no tin b, va mi y c xp hng nh l ngun ci th ba gy t vong Hoa K v nh hng n hn nm triu ngi M. Theo Vin Y t quc gia, y cng l duyn do ph thng nht ca chng sa st tr c ngi ln tui. |